期刊文献+

两种方法联合检测自身免疫性疾病中ANCA的临床意义 被引量:3

The clinical significance of ANCA in autoimmune diseases detected by the combination of immunoflourescence technique and western blotting test
下载PDF
导出
摘要 目的评价间接免疫荧光法(IIF)和免疫印迹法检测抗中性粒细胞胞质抗体(ANCA)的临床意义。方法采用IIF和免疫印迹法联合对126例自身免疫性疾病患者的血清进行ANCA检测。结果在126例患者中类风湿关节炎(RA)、韦格纳肉芽肿瘤(WG)、皮肌炎(DM)和过敏性紫癜患者血清检测cANCA阳性与PR3-ANCA阳性是一一对应的;而在51例SLE患者中,有17例(33.3%)pANCA阳性,7例(13.7%)骨髓过氧化物酶(MPO)-ANCA阳性;在29例RA中3例(10.3%)pANCA阳性,而4例(13.7%)MPO-ANCA阳性。WG和ANCA相关性血管炎患者检测ANCA阳性率较高,分别为87.5%和93.7%。结论IIF一般情况下可以作为临床常规检测ANCA的筛选试验,免疫印迹法可以作为特异ANCA确证试验。二者联合应用可以提高ANCA的检出率,减少ANCA的误诊率。 Objective To evaluate the clinical significance by combining immunoflourescence technique(IIF)and Western blotting tests in detecting anti neutrophil cytoplasmic antibodies(ANCA).Methods ANCA fluorescent patterns and its target antigens in sera of 126patients with autoimmune disease were detected by IIF and Western blotting test.Results cANCA detected by IIF was nearly always directed against PR3-ANCA in the sera of the126patients,whereas among 51patients with SLE,17samples were positive for pANCA,7samples were positive for MPO-ANCA.Among 29patients with RA,3samples were positive for pANCA and 4samples were positive for MPO-ANCA.In the patients of WG and ANCA associated vasculitis,the positive rates of ANCA were 87.5%and 93.7%respectively.Conclusion The method of IIF under normal circumstances could be used for testing ANCA in clinical routine screening test,and the method of Western blotting test can be used as specific ANCA confirmatory test.Combination of the two tests can increase the detection rate and reduce the misdiagnosis rate of ANCA.
出处 《国际检验医学杂志》 CAS 2013年第19期2559-2561,共3页 International Journal of Laboratory Medicine
基金 国家临床重点专科建设项目经费资助项目
关键词 荧光抗体技术 间接 免疫印迹法 自身免疫疾病 fluorescent antibody technique,indirect immunoblotting autoimmune diseases
  • 相关文献

参考文献14

二级参考文献23

  • 1侯巍,惠艳.65例系统性红斑狼疮患者抗中性粒细胞胞浆抗体的检测分析[J].地方病通报,2005,20(2):98-99. 被引量:2
  • 2林善锬,卢燕雯.抗中性粒细胞胞浆抗体检测在肾脏病诊治中的应用[J].中国实用内科杂志,1995,15(6):337-339. 被引量:9
  • 3Watts R A, Lane S E, Bentham G, et al. Epidemiology of systemic vasculitie: a ten-year study in the United Kingdom. Arthritis Rheum, 2000, 43: 414-419.
  • 4Levy J. New aspects in the management of ANCA-positive vasculitis. Nephrol Dial Transplant, 2001, 16: 1314-1317.
  • 5Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with an tineutrophii cytoplasmic autoantibodies. N Engl J Med, 2003, 349: 36-44.
  • 6Nowack R, Gobel U, Klooker P, et al. Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with re nalinvolvement. J Am Soc Nephrol, 1999, 10:1965-1971.
  • 7Joy M S, Hogan S I., Jennette J C, et al. A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vaseulitis. Nephrol Dial Tranplant, 2005, 20: 2725- 2732.
  • 8Booth A D, Jayne D R, Kharbanda R K, et al. Infliximab improves endothelial dysfunction in systemic vasculitis: a mode of vascular inflammation. Circulation, 2004, 109: 1718-1723.
  • 9Stasi R, Stipa E, Del Poeta G, et al. Long-term observation of patients with anti-neutrophil cytoplasmic antibody associated vasculitis treated with rituximab. Rheumatology, 2006, 45:1432-1436.
  • 10蒋明,风湿病学,1995年,996页

共引文献28

同被引文献18

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部